EUVIMEDEUVIMED entdecken
Open Access

Quantitative flow ratio versus fractional flow reserve for guiding percutaneous coronary intervention: design and rationale of the randomised FAVOR III Europe Japan trial

Birgitte Krogsgaard Andersen, Martin Sejr-Hansen, Jelmer Westra, Gianluca Campo, Ashkan Efterkhari, Shengxian Tu, Javier Escaned, Lukasz Koltowski, Barbara E Stähli, Andrejs Erglis, Gediminas Jaruševičius, Greta Žiubrytė und 8 weitere

EuroIntervention · 2023

DOI: 10.4244/eij-d-21-00214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EuroIntervention, 2023. Verfasst von Birgitte Krogsgaard Andersen und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aarhus University Hospital, Skejby, Denmark. Hauptthemen laut MEDLINE: Coronary Stenosis, Fractional Flow Reserve, Myocardial, Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantitative flow ratio (QFR) is a computation of fractional flow reserve (FFR) based on invasive coronary angiographic images. Calculating QFR is less invasive than measuring FFR and may be associated with lower costs. Current evidence supports the call for an adequately powered randomised comparison of QFR and FFR for the evaluation of intermediate coronary stenosis. The aim of the FAVOR III Europe Japan trial is to investigate if a QFR-based diagnostic strategy yields a non-inferior 12-month clinical outcome compared with a standard FFR-guided strategy in the evaluation of patients with intermediary coronary stenosis. FAVOR III Europe Japan is an investigator-initiated, randomised, clinical outcome, non-inferiority trial scheduled to randomise 2,000 patients with either 1) stable angina pectoris and intermediate coronary stenosis, or 2) indications for functional assessment of at least 1 non-culprit lesion after acute myocardial infarction. Up to 40 international centres will randomise patients to either a QFR-based or a standard FFR-based diagnostic strategy. The primary endpoint of major adverse cardiovascular events is a composite of all-cause mortality, any myocardial infarction, and any unplanned coronary revascularisation at 12 months. QFR could emerge as an adenosine- and wire-free alternative to FFR, making the functional evaluation of intermediary coronary stenosis less invasive and more cost-effective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary StenosisFractional Flow Reserve, MyocardialMyocardial InfarctionPercutaneous Coronary InterventionHumansCoronary AngiographyCoronary VesselsEuropeJapanPredictive Value of TestsProspective StudiesSeverity of Illness IndexRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.
  • Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy and Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.
  • Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Hospital Clinico San Carlos IdISSC, Complutense University of Madrid, Madrid, Spain.
  • Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Zitieren

APA

Andersen, B. K., Sejr-Hansen, M., Westra, J., Campo, G., Efterkhari, A., Tu, S., Escaned, J., Koltowski, L., Stähli, B. E., Erglis, A., Jaruševičius, G., Žiubrytė, G., Råmunddal, T., Liu, T., Wijns, W., Landmesser, U., Maillard, L., Matsuo, H., Christiansen, E. H., & Holm, N. R. (2023). Quantitative flow ratio versus fractional flow reserve for guiding percutaneous coronary intervention: design and rationale of the randomised FAVOR III Europe Japan trial. EuroIntervention. https://doi.org/10.4244/eij-d-21-00214

Vancouver

Andersen BK, Sejr-Hansen M, Westra J, Campo G, Efterkhari A, Tu S, et al. Quantitative flow ratio versus fractional flow reserve for guiding percutaneous coronary intervention: design and rationale of the randomised FAVOR III Europe Japan trial. EuroIntervention. 2023. doi:10.4244/eij-d-21-00214

BibTeX
@article{Andersen2023,
  author = {Andersen, Birgitte Krogsgaard and Sejr-Hansen, Martin and Westra, Jelmer and Campo, Gianluca and Efterkhari, Ashkan and Tu, Shengxian and Escaned, Javier and Koltowski, Lukasz and Stähli, Barbara E and Erglis, Andrejs and Jaruševičius, Gediminas and Žiubrytė, Greta and Råmunddal, Truls and Liu, Tommy and Wijns, William and Landmesser, Ulf and Maillard, Luc and Matsuo, Hitoshi and Christiansen, Evald Høj and Holm, Niels Ramsing},
  title = {Quantitative flow ratio versus fractional flow reserve for guiding percutaneous coronary intervention: design and rationale of the randomised FAVOR III Europe Japan trial},
  journal = {EuroIntervention},
  year = {2023},
  doi = {10.4244/eij-d-21-00214}
}
Kostenlos starten →